Stay informed with the latest updates for the inheritable blood disorders community.

COVID-19
Industry Forms Alliance to Develop Potential Treatment for Patients with Serious COVID-19 Complications
Industry Forms Alliance to Develop Potential…
Industry
Updates on Product Availability During COVID-19 Outbreak
Updates on Product Availability During COVID-19 Outbreak
Industry
Female Scientist Conducting Research in Lab Analyzing Data
Three Concizumab Trials Halted by Novo Nordisk
Industry
Genentech Provides Updates on Hemlibra Product Particles
Medexus Acquires XINITY® from Aptevo
Industry
BioMarin Announces Three Year Updates on Investigational Gene Therapy
BioMarin Announces Three Year Updates on Investigational Gene Therapy
Industry
Pfizer Takes Over Development of Gene Therapy Candidate from Sangamo
Pfizer Takes Over Development of Gene Therapy Candidate from Sangamo
Industry
Regulators Clear Roche Deal to Acquire Spark
Regulators Clear Roche Deal to Acquire Spark
Industry
Bayer Announces Data from Jivi Extension Study
Bayer Announces Data from Jivi Extension Study
Industry
Sangamo and Pfizer Announce Progress in Gene Therapy Trial at ASH
Sangamo and Pfizer Announce Progress in Gene Therapy Trial at ASH
Industry
UniQure Announces Interim Hemophilia B Gene Therapy Trial Data
UniQure Announces Interim Hemophilia B Gene Therapy Trial Data
Industry
UniQure Reaches Enrollment Goal in Phase 3 Gene Therapy Trial
UniQure Reaches Enrollment Goal in Phase 3 Gene Therapy Trial
Industry
Investigational Marstacimab Shows Promise in Laboratory Assays
Investigational Marstacimab Shows Promise in Laboratory Assays
Industry
Sigilon’s SIG-001 Receives Orphan Drug Designation
Sigilon’s SIG-001 Receives Orphan Drug Designation
Industry
New Lab Test Screens for Inhibitors in Patients Receiving Hemlibra®
New Lab Test Screens for Inhibitors in Patients Receiving Hemlibra®
Industry
Analysis Compares Prophylaxis with Emicizumab vs FVIII Replacement
Analysis Compares Prophylaxis with Emicizumab vs FVIII Replacement